Clinical Trial Update: Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 proof-of-concept clinical trial evaluating DD-25 topical cream for psoriasis vulgaris. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• DD-25 Topical Cream

Snippet

Sponsor: Fortuderm Ltd. | Conditions: Psoriasis Vulgaris | Phase 1, Phase 2 | Status: UNKNOWN